TCOV
KYNB

Trust Company of Vermont’s Kyntra Bio KYNB Stock Holding History

Trust Company of Vermont’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1
Closed -$1K – 1024
2019
Q1 		$1K Buy
+1
New +$1.36K ﹤0.01% 946

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Trust Company of Vermont's KYNB Position: Q2 2019 in Review

Trust Company of Vermont sold out of Kyntra Bio (KYNB) in Q2 2019, closing a stake of 1 share — an estimated $1K sold.

Trust Company of Vermont first reported a position in KYNB in Q1 2019 and held it in 1 quarter. The position peaked at $1K in Q1 2019. 190 funds tracked by Wall St. Rank hold KYNB as of Q2 2019.

  • Trust Company of Vermont reported no remaining Kyntra Bio position as of Q2 2019 after selling out during the quarter.
  • Trust Company of Vermont sold 1 Kyntra Bio share in Q2 2019, an estimated $1K.
  • Trust Company of Vermont first reported a position in Kyntra Bio in Q1 2019 and held it in 1 quarter.
  • Trust Company of Vermont's Kyntra Bio position peaked at $1K in Q1 2019.
  • 190 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2019.

Based on Trust Company of Vermont's 13F filing for Q2 2019, filed 26 Jul 2019.